Phase II Study of AL-2178 (FID 109980) in the Treatment of Dry Eye

Alcon

Status and phase: Completed; Phase 3

Conditions: Dry Eye

Treatments: Drug: Rimexolone

Study type: Interventional

Funder types: Industry

Identifiers

NCT00471419

C-05-31

Details and patient eligibility

About

The purpose of this study is to see if Rimexolone (FID 109980) is a safe and effective treatment of dry eye.

Enrollment: 750 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• documented dry eye history
• ocular symptoms
• tear use
• dry eye ocular signs

Exclusion criteria

• Under 18

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind